Journal
REGENERATIVE MEDICINE
Volume 14, Issue 9, Pages 841-865Publisher
FUTURE MEDICINE LTD
DOI: 10.2217/rme-2018-0137
Keywords
adipose tissue; bone marrow; fibroblasts; gene expression; mesenchymal stem cells; placenta; transcriptome; umbilical cord
Categories
Funding
- Scientific Research Fund/Ministry of Higher Education/Amman/Jordan [MPH/1/41/2015]
Ask authors/readers for more resources
Aim: Variations in the clinical outcomes using mesenchymal stem cells (MSCs) treatments exist, reflecting different origins and niches. To date, there is no consensus on the best source of MSCs most suitable to treat a specific disease. Methods: Total transcriptome analysis of human MSCs was performed. MSCs were isolated from two adult sources bone marrow, adipose tissue and two perinatal sources umbilical cord and placenta. Results: Each MSCs type possessed a unique expression pattern that reflects an advantage in terms of their potential therapeutic use. Advantages in immune modulation, neurogenesis and other aspects were found. Discussion: This study is a milestone for evidence-based choice of the type of MSCs used in the treatment of diseases. [GRAPHICS]
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available